Key result
Cardiomyopathy-associated MYBPC3 25-bp deletion is prevalent in ~5% of South Asians but absent globally.
Why the study?
The distribution and frequency of the MYBPC3 25-base-pair deletion variant associated with familial cardiomyopathy in South Asia were not well characterized.
Observational (n=447)
Yes
May inform ancestry-specific cardiomyopathy genetic testing; extends evidence for the variant's restriction to Indian populations.
Heart failure is a leading cause of death of people in South Asia, and cardiomyopathy is a major cause of heart failure. Myosin binding protein C (MYBPC3) is expressed in the heart muscle, where it regulates the cardiac response to adrenergic stimulation and is important for the structural integrity of the sarcomere. Mutations in the MYBPC3 gene are associated with hypertrophic or dilated cardiomyopathies. A 25-base-pair deletion in intron 32 causes skipping of the downstream exon and is associated with familial cardiomyopathy. To date, this deletion is found primarily in India and South Asia, although it is also found at low frequency in Southeast Asia. In order to better characterise the distribution of this variant, we determined its frequency in 447 individuals from 19 populations, including 10 populations from India and neighbouring populations from Pakistan and Nepal. The deletion frequency is over 8% in some of our Indian samples, and it is not present in any of the populations we sampled outside of India. The differences in the deletion frequencies among populations in India are consistent with patterns of variation previously reported and with patterns we observed among Indian populations based on high-density SNP chip data. Our results indicate that the MYBPC3 deletion is primarily found among Indian populations and that its distribution is consistent with genome-wide patterns of variation in India.
No takes yet. Share an insight, caveat, or question.
Simonson et al. (2010) conducted an observational in Cardiomyopathy (n=447). MYBPC3 25-bp deletion vs. Populations outside of India was evaluated on Allele frequency of the MYBPC3 25-bp deletion. The cardiomyopathy-associated MYBPC3 25-bp deletion is present at an allele frequency of approximately 5% in Indian populations, reaching up to 10% in specific groups, but is completely absent in populations sampled outside of India.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: